The latest and trending news from around the world.
Eli Lilly and Company Stock: A Comprehensive Guide
Overview
Eli Lilly and Company (LLY) is a global leader in the pharmaceutical industry. The company has a rich history of innovation, and its products are used by millions of people around the world. LLY is a publicly traded company, and its stock is listed on the New York Stock Exchange.
Key Facts About Eli Lilly and Company
Headquarters: Indianapolis, Indiana
Founded: 1876
Employees: Over 33,000
Products: Pharmaceuticals, medical devices, and animal health products
Revenue: Over $28 billion (2021)
Stock Performance
LLY stock has performed well in recent years. The stock has outperformed the S&P 500 Index, and it has generated strong returns for investors.
Key Metrics
5-year return: Over 100%
10-year return: Over 200%
Dividend yield: 1.2%
Risks and Opportunities
Like all stocks, LLY stock carries some risks. However, there are also many opportunities for investors.
Risks
Competition from other pharmaceutical companies
Regulatory changes
Clinical trial failures
Opportunities
Strong pipeline of new products
Growing demand for pharmaceuticals
Expanding presence in emerging markets
Conclusion
Eli Lilly and Company is a strong company with a bright future. The company's stock is a good investment for investors who are looking for long-term growth.
